Top

Published in:

01-07-2018 | Brief Report

A Doctor is in the House: Stakeholder Focus Groups About Expanded Scope of Practice of Community Psychiatrists

Authors: Christina Mangurian, Chelsea Modlin, Lindsey Williams, Susan Essock, Nicholas S. Riano, Martha Shumway, John W. Newcomer, James W. Dilley, Dean Schillinger

Published in: Community Mental Health Journal | Issue 5/2018

Abstract

We sought to understand stakeholder perspectives on barriers to metabolic screening for people with severe mental illness. We additionally assessed the feasibility of expanding psychiatrists’ scope of practice to include treatment of cardiometabolic abnormalities. We conducted four focus groups among patients with severe mental illness, community psychiatrists, primary care providers, and public health administrators. Focus group transcripts were thematically analyzed. Three domains emerged: challenges with patient navigation of the complex health care system, problem list prioritization difficulties, and concern that treatment of cardiometabolic abnormalities were beyond the scope of practice of psychiatrists. Stakeholders agreed that navigating the health care system was challenging for this population and led to undertreatment of cardiometabolic risk factors. Expansion of psychiatrists’ scope of practice within community mental health appears acceptable to patients and may be a mechanism to improve cardiometabolic care among people with severe mental illness.

Available only for authorised users

Alakeson, V., Frank, R. G., & Katz, R. E. (2010). Specialty care medical homes for people with severe, persistent mental disorders. Health Affairs, 29(5), 867–873. https://doi.org/10.1377/hlthaff.2010.0080.CrossRefPubMed

Amiel, J. M., & Pincus, H. A., Gov’t, U. S., & Review], P. H. S. (2011). The medical home model: new opportunities for psychiatric services in the United States. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support. Current Opinion in Psychiatry, 24(6), 562–568. https://doi.org/10.1097/YCO.0b013e32834baa97.CrossRefPubMed

Appelbaum, P. S., & Grisso, T. (2001). MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research.

CDC. (2015). http://www.cdc.gov/nchs/data/ahcd/combined_tables/AMC_2009-2010_combined_web_table01.pdf. Accessed November 30, 2015.

Clark, N. G. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596.CrossRef

Colton, C. W., Manderscheid, R. W. (2006). Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease, 3(2), A42.PubMedPubMedCentral

Compton, M. T., Daumit, G. L., & Druss, B. G. (2006). Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: A preventive perspective. [Review]. Harvard Review of Psychiatry, 14(4), 212–222. https://doi.org/10.1080/10673220600889256.CrossRefPubMed

Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., et al. (2008). Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. [Comparative Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. Schizophrenia Research, 105(1–3), 175–187. https://doi.org/10.1016/j.schres.2008.07.006.CrossRefPubMedPubMedCentral

Davidson, S., Judd, F., Jolley, D., Hocking, B., Thompson, S., & Hyland, B. (2001). Cardiovascular risk factors for people with mental illness. [Research Support, Non-U.S. Gov’t]. The Australian and New Zealand Journal of Psychiatry, 35(2), 196–202.CrossRefPubMed

Druss, B. G. (2007). Improving medical care for persons with serious mental illness: Challenges and solutions. The Journal of Clinical Psychiatry, 68(Suppl 4), 40–44.PubMed

Druss, B. G., Marcus, S. C., Campbell, J., Cuffel, B., Harnett, J., Ingoglia, C., et al. (2008). Medical services for clients in community mental health centers: Results from a national survey. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Psychiatric Services, 59(8), 917–920. https://doi.org/10.1176/appi.ps.59.8.917.CrossRefPubMed

Druss, B. G., & von Esenwein, S. A. (2006). Improving general medical care for persons with mental and addictive disorders: Systematic review. [Research Support, N.I.H., Extramural Review]. General Hospital Psychiatry, 28(2), 145–153. https://doi.org/10.1016/j.genhosppsych.2005.10.006.CrossRefPubMed

Druss, B. G., von Esenwein, S. A., Glick, G. E., Deubler, E., Lally, C., Ward, M. C., et al. (2016). Randomized trial of an integrated behavioral health home: The Health Outcomes Management and Evaluation (HOME) Study. American Journal of Psychiatry, 174(3), 246–255.CrossRefPubMed

Druss, B. G., & Walker, E. R. (2011). Mental disorders and medical comorbidity. The Synthesis Project, 21, 1–26.

Essock, S. M., Covell, N. H., Leckman-Westin, E., Lieberman, J. A., Sederer, L. I., Kealey, E., et al. (2009). Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in New york state. Psychiatric Services, 60(12), 1595–1602. https://doi.org/10.1176/appi.ps.60.12.1595.CrossRefPubMed

Haupt, D. W., Rosenblatt, L. C., Kim, E., Baker, R. A., Whitehead, R., & Newcomer, J. W. (2009). Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. The American Journal of Psychiatry, 166(3), 345–353. https://doi.org/10.1176/appi.ajp.2008.08030383.CrossRefPubMed

Horvitz-Lennon, M., Kilbourne, A. M., & Pincus, H. A. (2006). From silos to bridges: Meeting the general health care needs of adults with severe mental illnesses. Health Affairs, 25(3), 659–669.CrossRefPubMed

Knodel, J. (1993). The design and analysis of focus group studies: A practical approach. In D. A. Morgan (Ed.), Successful focus groups: Advancing the state of the art. Newbury Park, CA: Sage Publications.

Kreuger, R. A. (1998). Analyzing and reporting focus group results. Thousand Oaks, CA: Sage Publications.CrossRef

Lambert, T. J., & Newcomer, J. W. (2009). Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. [Review]. The Medical Journal of Australia, 190(4 Suppl), S39–S42.PubMed

Lambert, T. J., Velakoulis, D., & Pantelis, C. (2003). Medical comorbidity in schizophrenia. [Research Support, Non-U.S. Gov’t]. The Medical Journal of Australia, 178, S67–S70.PubMed

Mangurian, C., Giwa, F., Shumway, M., Fuentes-Afflick, E., Perez-Stable, E. J., Dilley, J. W., et al. (2013). Primary care providers’ views on metabolic monitoring of outpatients taking antipsychotic medication. Psychiatric Services, 64(6), 597–599. https://doi.org/10.1176/appi.ps.002542012.CrossRefPubMedPubMedCentral

Mangurian, C., Newcomer, J. W., Vittinghoff, E., Creasman, J. M., Knapp, P., Fuentes-Afflick, E., et al. (2015). Diabetes screening among underserved adults with severe mental illness who take antipsychotic medications. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.6098.PubMedPubMedCentralCrossRef

McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. [Comparative Study Research Support, N.I.H., Extramural]. Schizophrenia Research, 80(1), 19–32. https://doi.org/10.1016/j.schres.2005.07.014.CrossRefPubMed

Morgan, D. (1988). Focus groups as qualitative research. Beverly Hills, CA: Sage Publications.

Morrato, E. H., Cuffel, B., Newcomer, J. W., Lombardo, I., Kamat, S., & Barron, J. (2009). Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Journal of Clinical Psychopharmacology, 29(1), 26–32. https://doi.org/10.1097/JCP.0b013e31819294cb.CrossRefPubMed

Morrato, E. H., Druss, B., Hartung, D. M., Valuck, R. J., Allen, R., Campagna, E., et al. (2010). Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. [Comparative Study Multicenter Study Research Support, Non-U.S. Gov’t]. Archives of General Psychiatry, 67(1), 17–24. https://doi.org/10.1001/archgenpsychiatry.2009.179.CrossRefPubMed

HR2646: Helping Families in Mental Health Crisis Act (R. T. Murphy, Trans.). (2016) 114th Congress (114 edn.).

Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., et al. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86(1–3), 15–22. https://doi.org/10.1016/j.schres.2006.06.026.CrossRefPubMed

Newcomer, J. W. (2005). Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs, 19(Suppl 1), 1–93.PubMed

Newcomer, J. W., & Hennekens, C. H. (2007). Severe mental illness and risk of cardiovascular disease. [Research Support, N.I.H., Extramural]. JAMA: The Journal of the American Medical Association, 298(15), 1794–1796. https://doi.org/10.1001/jama.298.15.1794.CrossRefPubMed

Olfson, M., Gerhard, T., Huang, C., Crystal, S., & Stroup, T. S. (2015). Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2015.1737.PubMedCentralCrossRefPubMed

Palmer, B. W., Dunn, L. B., Appelbaum, P. S., Mudaliar, S., Thal, L., Henry, R., et al. (2005). Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: Comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. [Comparative Study Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, P.H.S.]. Archives of General Psychiatry, 62(7), 726–733. https://doi.org/10.1001/archpsyc.62.7.726.CrossRefPubMed

Parameswaran, S. G., Chang, C., Swenson, A. K., Shumway, M., Olfson, M., & Mangurian, C. V. (2013). Roles in and barriers to metabolic screening for people taking antipsychotic medications: A survey of psychiatrists. Schizophrenia Research, 143(2–3), 395–396. https://doi.org/10.1016/j.schres.2012.08.031.CrossRefPubMed

Reilly, S., Planner, C., Gask, L., Hann, M., Knowles, S., Druss, B., et al. (2013). Collaborative care approaches for people with severe mental illness. Cochrane Database Syst Rev, (11). https://doi.org/10.1002/14651858.CD009531

Rein, A. (2007). Navigating health care: Why it’s so hard and what can be done to make it easier for the average consumer. In R.W.J.F. AcadamyHealth (Ed.), AcademyHealth Issue Brief.

Scharf, D. M., Eberhart, N. K., Schmidt, N., Vaughan, C. A., Dutta, T., Pincus, H. A., et al. (2013). Integrating primary care into community behavioral health settings: Programs and early implementation experiences. Psychiatric Services, 64(7), 660–665.CrossRefPubMed

Scharf, D.M., Eberhart, N.K., Hackbarth, N.S., Horvitz-Lennon, M., Beckman, R., Han, B., Lovejoy, S.L., Pincus, H.A., Burnam, M.A. (2014). Evaluation of the SAMHSA primary and behavioral health care integration (PBHCI) Grant Program: Final Report (Task 13).

SocioCultural Research Consultants LLC. (2015). Dedoose Web application for managing, analyzing, and presenting qualitative and mixed method research data (6.1.18 edn.). Los Angeles, CA.

Steinø, P., Jørgensen, C., & Christoffersen, J. K. (2013). Psychiatric claims to the Danish Patient Insurance Association have low recognition percentages. Danish Medical Journal, 60(8), A4621-A4621.

Stewart, D. W., & Shamdasani, P. N. (1990). Focus groups: Theory and practice. Newbury Park, CA: Sage Publications.

Unutzer, J., Katon, W., Callahan, C. M., Williams, J. W. Jr., Hunkeler, E., Harpole, L., et al. (2002). Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA: The Journal of the American Medical Association, 288(22), 2836–2845.CrossRefPubMed

Vanderlip, E. R., Raney, L. E., & Druss, B. G. (2016). A Framework for Extending Psychiatrists’ Roles in Treating General Health Conditions. American Journal of Psychiatry, 173(7), 658–663.CrossRefPubMed

Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005). Twelve-month use of mental health services in the united states: Results from the national comorbidity survey replication. Archives of General Psychiatry, 62(6), 629–640. https://doi.org/10.1001/archpsyc.62.6.629.CrossRefPubMed

Title: A Doctor is in the House: Stakeholder Focus Groups About Expanded Scope of Practice of Community Psychiatrists
Authors: Christina Mangurian
Chelsea Modlin
Lindsey Williams
Susan Essock
Nicholas S. Riano
Martha Shumway
John W. Newcomer
James W. Dilley
Dean Schillinger
Publication date: 01-07-2018
Publisher: Springer US
Published in: Community Mental Health Journal / Issue 5/2018
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-017-0198-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A Doctor is in the House: Stakeholder Focus Groups About Expanded Scope of Practice of Community Psychiatrists

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2018

Mental Health Consultation Among Ontario’s Immigrant Populations

Associated Factors of Self-Rated Mental Health Status in Southwestern Iran: Using SCAD Regression Model in a Population-Based Study

Correction to: Mental Health Needs and Psychoactive Drug Use in a User Population of the Family Health Strategy (FHS) in Ribeirão Preto, São Paulo, Brazil

Exploring Peer Support Needs of Caregivers for Youth with Mental Illness or Addictions Concerns in Family Navigation Services

Satisfaction with Mental Health Navigation Services: Piloting an Evaluation with a New Scale

Increasing Rate of Psychological Distress in Urban Households: How Does Income Matter?